The combination of strong GLP-1 appetite suppression with meaningful GIP-mediated metabolic improvement creates a synergistic effect that exceeds what either receptor could produce alone, a principle similar to why peptide stacking sometimes outperforms individual compounds
Tirzepatide: commonly researched in GLP-1 and GIP pathway models
** In-office visits may be required based on the discretion of your provider
The difference depends on whether the medication is being used with clinical oversight, clear dosing, appropriate monitoring, and a larger plan for metabolic health, muscle preservation, cardiovascular risk reduction, and long-term function
Many telehealth providers of nutrition support or general telehealth services are now offering GLP-1 prescriptions and support, including platforms with millions of users like Noom (Series F) and WeightWatchers Clinic (public)
Why is Retatrutide receiving so much attention